Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Announcement of change in the total number of votes in AB SKF
AB SKF does not hold any own shares. AB SKF does not hold any own shares. Aktiebolaget SKF (publ) Information in this press release contains information that AB SKF is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication on31 March 2025at08:00 CEST. For further information, please contact:Press Relations: Carl Bjernstam, +46 31-337 2517; +46 722 201 893;
[email protected]
Investor Relations:...
PR Newswire
31/03/2025
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and…
Conference call and webcast scheduled for Thursday, April 3, 2025, at 8:00 am EDT / 2:00 pm CEST PARIS and CAMBRIDGE, Mass., March31, 2025(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that it will report its financial results for the fourth quarter and full year...
Nasdaq GlobeNewswire
31/03/2025
Casino Group: Icade makes a first acquisition of 9 sites from Casino Group
Icade makes a first acquisition of 9 sites from Casino Group Pursuant to the binding agreement signed in December 2024 for the acquisition of a property portfolio of 11 sites, Icade and Casino Group are pleased to announce that Icade acquired the first 9 sites for a total of €32m.These sites, consisting of car parks, undeveloped land, business premises and ancillary lots adjoining stores operated by third parties, are located in Marseille (Bouches-du-Rhône), Montpellier (Hérault),...
Nasdaq GlobeNewswire
31/03/2025
Valneva Submits Adolescent Label Extension Application for its Chikungunya…
Saint Herblain (France), March 31, 2025–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) to potentially expand the use of its chikungunya vaccine, IXCHIQ ®, currently approved in adults 1, to adolescents aged 12 to 17 years in the UK. This submission follows the recent positive opinion of the...
Nasdaq GlobeNewswire
31/03/2025
Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus…
After nearly seven years as a member of the Executive Committee of Novartis (ECN), Klaus Moosmayer will pursue his next chapter of leadership outside of NovartisKaren Hale to drive the next phase of enterprise alignment for our Legal and ERC functionsBasel, March 31, 2025– Novartis announced today the appointment of Karen Hale to the expanded role of Chief Legal and Compliance Officer for Novartis, effective April 14, 2025. She will continue to report to Vas Narasimhan, M.D...
Nasdaq GlobeNewswire
31/03/2025
Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior…
Rybelsus ®reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial 1.Data were presented at the American College of Cardiology's (ACC) Annual Scientific Session and Expo in Chicago, US, while simultaneously published today in New England Journal of Medicine 2.Rybelsus ®, the only approved oral GLP-1 medicine, demonstrated this risk reduction on top of...
Nasdaq GlobeNewswire
29/03/2025
Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and…
Ozempic ®improved maximum walking distance by 13% vs placebo in adults with type 2 diabetes and peripheral artery disease (PAD) in the phase 3 STRIDE trial 1.Data were presented at the American College of Cardiology's (ACC) Annual Scientific Session and Expo in Chicago, US, while simultaneously published today in The Lancet 2.Approximately 230 million people globally have PAD, a severe form of atherosclerotic cardiovascular disease 3, and nearly one in three people with PAD have...
Nasdaq GlobeNewswire
29/03/2025
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides…
FINANCIAL HIGHLIGHTSTotal revenue of Junshi Biosciences was approximately RMB1,948 million in 2024, representing an increase of approximately 30% compared to 2023, which was mainly due to the increase in revenue from pharmaceutical products, in particular: the domestic sales revenue of our core product, toripalimab, was approximately RMB1,501 million, representing an increase of approximately 66% compared to 2023.Total research and development (“R&D”) expenses of the company were...
Nasdaq GlobeNewswire
29/03/2025
Press Release: Qfitlia approved as the first therapy in the US to treat…
Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first antithrombin-lowering therapy in hemophilia, offers consistent protection with as few as six injections a year via a prefilled pen or vial and syringeUnique mechanism helps reduce the frequency of bleeding episodes for people with hemophilia Paris, March 28, 2025. The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first...
Nasdaq GlobeNewswire
28/03/2025
Casino Group: Asset Sale
Casino Group sells €71m of real estate assets to Groupement Les Mousquetaires or substitute buyers Following the agreement signed at the end of 2024 1with Groupement Les Mousquetaires for the sale of 69 real estate assets, Casino Group announces that it has finalised, during the first quarter of 2025, sales of 61 assets for a price of €71 million paid by Groupement Les Mousquetaires companies or substitute buyers.These assets mainly comprise car parks, service stations, supermarket...
Nasdaq GlobeNewswire
28/03/2025
FemTech Leaders Willow and Elvie Unite to Advance the Next Revolution in…
Sarah O'Leary, CEO of Willow, said: "Our goal is to elevate the maternal experience with inventive solutions to support and empower mothers. Acquiring Elvie, a deeply respected innovator in the women's health category, puts us in a leadership position to continue innovating for moms and drive meaningful, global advancements in women's and maternal health. We are thrilled to welcome the Elvie brand to the Willow family." Sarah O'Leary, CEO of Willow, said: "Our goal is to elevate…
PR Newswire
28/03/2025
FDA approves Novartis radioligand therapy Pluvicto® for earlier use before…
Ad hoc announcement pursuant to Art. 53 LR New indication approximately triples eligible patient population, allowing Pluvicto ®to be used after one androgen receptor pathway inhibitor (ARPI) and now before chemotherapyPluvicto significantly reduced risk of progression or death by 59% and more than doubled median radiographic progression-free survival (rPFS) vs. change in ARPI in Phase III PSMAfore trial*Approximately half of patients do not live long enough to receive...
Nasdaq GlobeNewswire
28/03/2025
AETHER FINANCIAL SERVICES POST CLOSING AGENT
AETHER FINANCIAL SERVICESPOST CLOSING AGENT On 26 February 2024, CASINO, GUICHARD-PERRACHON (the "Company"), a public limited company, incorporated in France with registered number 554 501 171 RCS Saint-Etienne, announced that, by judgments dated 26 February 2024, the Paris Commercial Court approved the accelerated safeguard plans for the Company setting the duration of this plan at 4 years. The financial restructuring was completed on 27 March 27 2024.To date, some bondholders...
Nasdaq GlobeNewswire
28/03/2025
NTG Nordic Transport Group A/S – Annual General Meeting 2025
Company announcement no. 6-2528 March 2025 NTG Nordic Transport Group A/S – Annual General Meeting 2025 Today, at 14:00, NTG Nordic Transport Group A/S (“NTG” or the “Company”), CVR no. 12 54 61 06, held its Annual General Meeting at Glostrup Park Hotel, Hovedvejen 41, 2600 Glostrup, Denmark.All proposals presented to the General Meeting were adopted: Items 1-3The General Meeting acknowledged the management's report on NTG's activities in the past financial year and NTG's audited...
Nasdaq GlobeNewswire
28/03/2025
Pharmacy Automation Market is Anticipated to Register 7.6% CAGR through 2031
Recent Development on Pharmacy Automation Market Growth, Development Analysis and Precise Outlook By 2031
DLR
28/03/2025
Cytogenetics Market Projected to Reach $5.5 Billion by 2031, Growing at a CAGR…
Key Market Drivers and Trends Key Market Drivers and Trends The cytogenetics market is experiencing significant growth driven by rising prevalence of genetic disorders and cancer, along with increased adoption of molecular cytogenetic techniques. Advances in next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA) have transformed genetic diagnostics, enabling more precise and rapid identification of chromosomal abnormalities...
PR Newswire
28/03/2025
Metagenomics Market to Reach $6.71 Billion by 2031, Growing at a CAGR of 15.6%…
Key Market Drivers and Trends Key Market Drivers and Trends The metagenomics market is witnessing robust growth due to the rising adoption of next-generation sequencing (NGS) technologies in microbiome research, disease diagnostics, and environmental monitoring. The ability of metagenomic sequencing to analyze complex microbial communities without the need for culturing is revolutionizing pathogen detection, antibiotic resistance studies, and precision medicine. Increasing investments...
PR Newswire
28/03/2025
BIRKENSTOCK OPENS CONCEPT STORE IN HISTORIC ZHANGYUAN, MARKING A NEW CHAPTER IN…
Nestled in one of Shanghai's most historic and vibrant areas, the new store seamlessly blends tradition with modernity. Thoughtfully designed to honor Shanghai's architectural heritage while embracing BIRKENSTOCK's minimalist aesthetic, the space seamlessly merges past and present. Nestled in one ofShanghai'smost historic and vibrant areas, the new store seamlessly blends tradition with modernity. Thoughtfully designed to honorShanghai'sarchitectural heritage while embracing...
PR Newswire
28/03/2025
JIECANG & LOGICDATA at CIFF 2025: Leading the Future of Electric Standing Desk…
The electric standing desk market is facing intense competition, particularly in commercial, home, and gaming sectors. As businesses embrace smarter, flexible, and sustainable office solutions, JIECANG and LOGICDATA are committed to helping brands adapt to these evolving demands. Their innovative technologies are designed to meet the growing demand for intelligent, ergonomic, and adaptable workspaces. The electric standing desk market is facing intense competition, particularly in commercial,...
PR Newswire
28/03/2025
Purina Institute Announces the Purina Institute Global Summit 2025
The Purina Institute Global Summit 2025 will foster discussions on a variety of topics at the forefront of companion animal science, such as: The Purina Institute Global Summit 2025 will foster discussions on a variety of topics at the forefront of companion animal science, such as: Attendees will have the opportunity to learn from and engage virtually with a group of experts providing diverse perspectives to explore future opportunities to advance pet health. Speakers include: "The…
PR Newswire
28/03/2025
DermRays Announces UK Amazon Store Launch in March 2025, Featuring Cutting-Edge…
The launch of the UK Amazon store marks a significant milestone in DermRays' mission to expand its global reach. By partnering with Amazon, DermRays aims to provide UK customers with a seamless shopping experience, including faster delivery, reliable customer service, and easy access to its award-winning products. The launch of the UK Amazon store marks a significant milestone in DermRays' mission to expand its global reach. By partnering with Amazon, DermRays aims to...
PR Newswire
28/03/2025
Pharming Group to participate in April investor conferences
Leiden, the Netherlands, March 28, 2025:Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conferences in the month of April:Van Lanschot Kempen Life Sciences Conference 2025, Amsterdam, NL, April 2-3, 202524th Annual Needham Virtual Healthcare Conference, April 7-10, 2025Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on...
Nasdaq GlobeNewswire
28/03/2025
SprintRay Inc. Announces API Integration with Align Technology's iTero™…
The Midas Digital Press, combined with next-generation restorative materials, further refines the workflow by delivering stronger, more esthetic, and highly durable printed restorations. This innovation allows dentists to embrace chairside technology with minimal effort, offering high-quality, patient-ready restorations in a single visit. The Midas Digital Press, combined with next-generation restorative materials, further refines the workflow by delivering stronger, more esthetic, and highly...
PR Newswire
28/03/2025
Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly…
Positions Curium as leading manufacturer of Lu-177 isotopeBrings innovative R&D expertise and pipeline to Curium Enhances Curium's SPECT & PET geographical coverage and supply chainPARIS, March28, 2025(GLOBE NEWSWIRE) -- Curium Pharma (“Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products Co. (Monrol), a leading nuclear medicine player, which is headquartered in Istanbul, Turkey...
Nasdaq GlobeNewswire
28/03/2025
Altri Comunicati
